Showing results (161-170 of 227) with videos related to
Sort By:
Pageof 23
The American Journal of Gastroenterology|November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the PouchMaia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.American Journal of Respiratory Cell and Molecular Biology|March 16, 2013
X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosisIyabode O Ajayi, Thomas H Sisson, Peter D R Higgins, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 30, 2021
A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel DiseaseJeffrey A Berinstein, Shirley A Cohen-Mekelburg, Gillian M Greenberg, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 21, 2018
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative ColitisJeffrey A Berinstein, Calen A Steiner, Randolph E Regal, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.Journal of Patient-Reported Outcomes|June 12, 2018
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diaryPeter D R Higgins, Gale Harding, Dennis A Revicki, et al.Pageof 23